NCT00412854
- Conditions
- Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +7 more
- Locations
-
- GSK Investigational Site Mengshan, China
- GSK Investigational Site Wuzhou, China
Clinical trial condition
Gram-Positive Bacterial Infections
Explore clinical trials studying Gram-Positive Bacterial Infections. Study availability and eligibility vary by location and protocol.
2,600 public trials
261 recruiting studies
Gram-Positive Bacterial Infections trial results
NCT00635128
- Conditions
- Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +24 more
- Locations
-
- GSK Investigational Site Ettenheim, Baden-Wurttemberg, Germany
- GSK Investigational Site Kehl, Baden-Wurttemberg, Germany
- GSK Investigational Site Oberkirch, Baden-Wurttemberg, Germany
- GSK Investigational Site Offenburg, Baden-Wurttemberg, Germany
NCT01449812
- Conditions
- Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +11 more
- Locations
-
- GSK Investigational Site Wuzhou, Guangxi, China
- GSK Investigational Site Wuzhou, Guangxi, China
Completed
Immunogenicity and Safety of Booster Dose of BoostrixTM Polio Vaccine in Previously Boosted Adults
NCT01323959
- Conditions
- Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +19 more
- Locations
-
- GSK Investigational Site Derval, France
- GSK Investigational Site La Chapelle-Basse-Mer, France
- GSK Investigational Site La Riche, France
- GSK Investigational Site Nantes, France
NCT00610168
- Conditions
- Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +12 more
- Locations
-
- GSK Investigational Site Turku, Finland
Completed
Study to Asses DTPw-HBV/Hib at 15-18 Months (m) and Mencevax™ ACW at 24 to 30 m in Primed Subjects
NCT00317109
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Blood-Borne Infections, +23 more
- Locations
-
- GSK Investigational Site Brits, South Africa
- GSK Investigational Site Ga-Rankuwa, South Africa
- GSK Investigational Site Rooihuiskraal, South Africa
Completed
Immunogenicity and Safety of Boostrix Polio Vaccine as a Booster Dose in 5 to 6-year-old Children.
NCT00871000
- Conditions
- Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +19 more
- Locations
-
- GSK Investigational Site Genoa, Liguria, Italy
- GSK Investigational Site Milan, Lombardy, Italy
- GSK Investigational Site Novara, Piedmont, Italy
- GSK Investigational Site Cagliari, Sardinia, Italy
NCT00325143
- Conditions
- Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +23 more
- Locations
-
- GSK Investigational Site Singapore
- GSK Investigational Site Singapore
- GSK Investigational Site Singapore
NCT00696423
- Conditions
- Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +7 more
- Locations
-
- GSK Investigational Site Liucheng County, Guangxi, China
- GSK Investigational Site Mengshan, China
- GSK Investigational Site Wuzhou, China
NCT00964028
- Conditions
- Acellular Pertussis, Actinomycetales Infections, Bacterial Infections, +23 more
- Locations
-
- GSK Investigational Site Wuzhou, Guangxi, China